Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target...

Area of Science:

• Biochemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Kinases are crucial drug targets, but their inhibition can be promiscuous.
• Understanding kinase inhibitor binding is vital for drug development.

Purpose of the Study:

• To identify representative kinases whose compound binding characteristics reflect those of numerous other kinases.
• To streamline compound testing strategies in kinase inhibitor development.

Main Methods:

• Systematic exploration of compound-based relationships between kinases using a curated inhibitor collection.
• Network analysis to identify kinases with shared inhibitor profiles.
• Identification of small kinase combinations representing larger kinase families.

Main Results:

• Individual kinases were identified that share over 50 inhibitors with more than 100 other kinases.
• Combinations of three to four kinases were found to represent approximately 150 kinases across the human kinome.
• These representative kinases exhibit shared compound-binding characteristics.

Conclusions:

• A small set of kinases can serve as surrogates for evaluating compound promiscuity.
• Prioritizing testing on these representative kinases can inform medicinal chemistry practices.
• This approach may optimize early-stage drug candidate assessment for kinase inhibition potential.